At Biosynth, we are proud to be a PE-backed global leader in complex chemical and biochemical solutions. Our ambition is powered by exceptional people whose expertise and passion drive us forward. We are now seeking an outstanding Head of Financial Planning & Analysis (FP&A) to join our dynamic organisation and play a pivotal role in shaping our financial strategy and future growth.
About the Role
As Head of FP&A, you will lead a high-performing team responsible for delivering strategic commercial insights and forward-looking analysis to guide decision-making across the business. Partnering closely with our C-Suite leadership and private equity stakeholders, you will help steer both organic and inorganic growth initiatives while championing data-driven excellence.
This is an influential, fast-paced role at the heart of our international life sciences business, offering the opportunity to make a tangible impact on value creation.
Key Responsibilities
* Strategic Planning & Business Partnering
o Drive the annual planning, budgeting, and forecasting cycles.
o Partner with divisional leaders to align financial planning with business strategy.
o Support M&A evaluation and integration alongside Corporate Development.
* Reporting & Insights
o Lead monthly financial close and reporting to executive leaders, investors, and lenders.
o Develop and maintain dashboards and KPIs to monitor performance.
o Provide customer and product profitability analysis to inform commercial decisions.
* Systems & Process Improvement
o Promote automation and self-service analytics across the business.
o Partner with IS to enhance SAP reporting capability and data integrity.
* Leadership
o Lead and develop two FP&A Managers, fostering a high-performance culture.
o Position Finance as a trusted business partner across the organisation.
Key Deliverables
* Timely and consistent reporting to C-Suite and lenders.
* Delivery of strategic projects and scenario analyses.
* High-quality board presentations and investor materials.
* Continuous improvement of forecasting accuracy and planning processes.
* Monthly financial reporting, half-year forecasts, annual budgets.
Candidate Requirements
We are looking for a commercially minded, strategic thinker who thrives in a dynamic environment and enjoys working cross-functionally to drive business success.
Essential Qualifications & Experience
* University degree in Business and/or Accounting.
* 10+ years' experience in FP&A or group financial leadership roles.
* Proven track record leading FP&A in a high-growth, PE-backed environment.
* Experience influencing senior stakeholders and driving strategic outcomes.
* Advanced Excel and financial modelling capability.
* Strong SAP proficiency and familiarity with manual ERP data extraction.
* Fluent in English
* Happy to work from our site on a hybrid basis, 2-3 days a week
Desirable
* Professional accounting qualification (ACCA/CIMA/CFA).
* Knowledge of pharmaceutical, biotech, or medical device industries.
* Power BI experience.
* Additional European language skills (e.g., German, Dutch etc)
Skills & Behaviours
* Confident presenter with excellent communication and interpersonal skills.
* Strong commercial acumen; able to link financials to operational drivers.
* Resilient, adaptable, detail-oriented, and comfortable with change.
* Demonstrated ability to foster a high-performance team culture.
Working Model
This role is offered on a hybrid basis (2-3 days on site), with some travel required to other Biosynth sites as needed.
About us
Biosynth is an innovative life sciences reagents, custom synthesis and manufacturing services company headquartered in Staad, Switzerland. We are by scientists, for scientists, securing supply chains with consistent quality, across the globe. As a trusted supplier, manufacturer and partner to the pharmaceutical, life science and diagnostic industries, as well as food, agrochemical and cosmetic customers, we have facilities on three continents and a rapid global distribution network. Our main production laboratories are located in Switzerland, the UK, Slovakia and China, with peptide and antibody production in the US, the UK and the Netherlands. Enzyme projects are based in Austria, bioconjugation projects in Germany and biological IVD reagents in Ireland.